Government official: Coronavirus vaccine trial starts Monday
2042 Tuesday, 17 March, 2020, 19:10 The first participant in a clinical trial for a vaccine to protect against the new coronavirus will receive an experimental dose on Monday, according to a government official. The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle. The official who disclosed plans for the first participant spoke on condition of anonymity because the move has not been publicly announced. Public health officials say it will take a year to 18 months to fully validate any potential vaccine. |
Pig kidney transplanted into living person for first time (photo)
597021.03.2024, 20:48First person dies from Alaskapox virus
842312.02.2024, 18:06Record-breaking doctors' strike piles pressure on England's health service
1357903.01.2024, 19:30China Hospitals overwhelmed with children suffering pneumonia
1571823.11.2023, 10:18WHO Concerned by Report of Israeli Evacuation Warning to Gaza Al-Quds Hospital
970829.10.2023, 19:00Pakistan police bust organ trafficking ring that took kidneys from hundreds
1775320.10.2023, 23:42Israel-Hamas war live: Gaza humanitarian crisis deepens amid calls for aid
1752717.10.2023, 00:30Gaza: Nowhere to go, as humanitarian crisis reaches 'dangerous new low'
1697713.10.2023, 23:48